News
The ENHANCE Phase 3b clinical trial is evaluating the safety and efficacy of a modified treatment regimen of Briumvi for ...
Frexalimab was well tolerated and maintained disease control over two years in adults with relapsing MS in an open-label ...
Kenya is grappling with a crisis of internal party democracy as political outfits struggle to conduct grassroots elections.From violence and delays to “favouritism” and manipulation, party elections ...
Despite five losses in six games, Chennai Super Kings still have a chance to qualify for the IPL 2025 playoffs. Here’s what ...
Hundreds of thousands of Britons with more than £3,500 in savings could be landed an unexpected bill from the tax office.
MS Dhoni replaces Ruturaj Gaikwad as the captain of CSK. The five-time champions are currently languishing in the 9th place ...
A new nonstop flight from Jackson to Nashville is providing convenience for travelers and new opportunities for businesses.
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
The findings reinforce the potential of BRIUMVI in improving patient outcomes for those seeking an alternative to their previous anti-CD20 therapy. Furthermore, the article in CNS DRUGS offers an ...
For many people who live with migraine, exercise has been reported as a trigger for attacks. But studies also show that ...
Investors won't struggle to find fintech stocks to invest in. But there's one enterprise with a strong position among both merchants and consumers that deserves a closer look, especially since its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results